The most award winning
healthcare information source.
TRUSTED FOR FOUR DECADES.
A new Florida law that would limit Medicaid patients’ access to a number of costly prescription drugs has pharmaceutical producers angry. So irate in fact that the Pharmaceutical Research and Manufacturers of America (PRMA) has filed suit in a U.S. District Court in Tallahassee, FL, claiming that the new law violates federal Medicaid rules and asking for a preliminary injunction against the law until a full challenge can be made.
The law in question, which establishes a formulary for Medicaid drugs in an attempt to save the state $214 million in Medicaid spending, requires that physicians seek prior state authorization before prescribing more than 1,000 drugs. PRMA’s attorneys say that Florida failed to appoint a committee to review and implement changes to Medicaid formularies as mandated by federal Medicaid rules.